Molecular-Based Score inspired on metabolic signature improves prognostic stratification for myelodysplastic syndrome
Abstract Deregulated cellular energetics is formally incorporated as an emerging hallmark of cancer, however little is known about its processes in myelodysplastic syndromes (MDS). Using transcriptomic data of CD34+ cells from 159 MDS patients and 17 healthy donors, we selected 37 genes involved in...
Guardado en:
Autores principales: | Juan L. Coelho-Silva, Douglas R. A. Silveira, Diego A. Pereira-Martins, Cesar A. O. Rojas, Antonio R. Lucena-Araujo, Eduardo M. Rego, João A. Machado-Neto, Israel Bendit, Vanderson Rocha, Fabiola Traina |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ba9e4b1885747c1968531cbed9acd10 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessing the prognostic utility of smoldering multiple myeloma risk stratification scores applied serially post diagnosis
por: Alissa Visram, et al.
Publicado: (2021) -
DIAGNOSTIC APPLICATION AND CLINICAL SIGNIFICANCE OF FCM WELLS SCORING SYSTEM IN MYELODYSPLASTIC SYNDROMES
por: Reyhan Aliyeva, et al.
Publicado: (2021) -
Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients
por: Parisi S, et al.
Publicado: (2021) -
Managing myelodysplastic symptoms in elderly patients
por: R Ria, et al.
Publicado: (2009) -
Usefulness of the CHADS2 and R2CHADS2 scores for prognostic stratification in patients with coronary artery disease
por: Li Y, et al.
Publicado: (2018)